Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia

Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
Conditions:   Relapsed Pediatric ALL;   Relapsed Pediatric AML;   Refractory Acute Myeloid Leukemia;   Refractory Acute Lymphoblastic Leukemia
Intervention:   Drug: Daunorubicin
Sponsor:   Children’s Mercy Hospital Kansas City
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 25, 2020 / by / in
Comments